HVAD™ performance tracker
Clinical experience with modified controller software
References to the “modified controller” refer to the alternate pump start algorithm within the controller software that may be able to restart a pump if the standard controller is unsuccessful in restarting a stopped pump (the availability of this alternate pump start algorithm was communicated via an urgent medical device communication in June 2022). The software in the modified controller has not been approved as being safe or effective for use by the U.S. Food and Drug Administration or any other regulatory authorities, which means it has not been tested to the same level as software in an approved medical device and comes with risk. As such, the modified controller with unapproved software is not available in all geographies. The modified controller should only be used if the pump has stopped, and the standard, commercially available controller is unsuccessful at restarting the pump.
As of June 30, 2025, there have been 42 instances where a controller with the modified algorithm has been used in an attempt to restart an HVAD™ pump. The pump restarted in 33 of the 42 instances. Of the 33 restarts, one was a Subgroup 1 patient, two were Subgroup 2 patients, 12 were Subgroup 3 patients, and 18 were General Population patients. No adverse events have been reported or evidence provided that use of the controller with the modified algorithm has adversely impacted the patient and/or their pump within the 33 successful use cases.
For the nine unsuccessful use cases, one involved a Subgroup 2 patient, two involved Subgroup 3 patients, and six involved General Population patients. The clinical information is as follows:
It is not known if any of these results will be typical or representative.